Login to MyKarger

New to MyKarger? Click here to sign up.

Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.


Proteomics and Metabolomics in Psychiatry

Editor(s): Martins-de-Souza D. (Campinas/Munich) 

Status: available   
Publication year: 2014
Buy this book
Digital Version: CHF 92.00, EUR 86.00, USD 108.00
Print Version: CHF 92.00, EUR 86.00, USD 108.00
The final prices may differ from the prices shown due to specifics of VAT rules, postage and handling.
Order this title

You already have online access to this title. If you would like to buy a personal digital or print copy, please click here.

This book belongs to
Advances in Biological Psychiatry , Vol. 29
Editor(s): Kaschka W.P. (Ravensburg) 
Gattaz W.F. (São Paulo) 
VIII + 142 p., 9 fig., 1 in color, 10 tab., hard cover, 2014
Status: available   
ISSN: 0378-7354
e-ISSN: 1662-2774

Unravel the latest advances in molecular psychiatry from a proteomics and metabolomics perspective
This publication compiles data generated by proteomics and metabolomics about psychiatric disorders. Leading researchers in these fields review the basic principles of proteomics and metabolomics and propose the new directions to be followed in molecular psychiatry. The chapters divided into two sections – Schizophrenia/Psychotic Disorders and Mood Disorders – deal with findings in diverse tissues from human and preclinical models in order to unravel the biology and biochemistry behind the establishment and course of these illnesses as well as potential biomarkers for clinical applications. More than an update, this publication indicates the next steps to discover biomarkers and understand psychiatric disorders more comprehensively.
This publication is valuable reading for psychiatrists, neuroscientists and analytical chemists interested in the basics of proteomics and metabolomics, psychiatric definitions and the most advanced hypotheses about the pathobiology of schizophrenia, depression and bipolar disorder.